SCHEMBL4845371

SCHEMBL4845371

COC(=O)C(c1ccc(OCCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3cc(C(F)(F)F)ccc3Cl)cc2)cc1)C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.39
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA4 P22748 2/20 0.37
CA9 Q16790 2/20 0.37
RORC P51449 5/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 1/20 0.35
ALDH1A1 P00352 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
MMP8 P22894 2/20 0.34
MMP3 P08254 1/20 0.34
ADAMTS4 O75173 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4832894 0.94 FFAR4 (0.40) FFAR4CA12CA1CA2CA4
SCHEMBL4844640 0.94 FFAR4 (0.39) FFAR4CA12CA1CA2CA4
SCHEMBL4842437 0.91 FFAR4 (0.41) FFAR4CA12CA1CA2CA4
SCHEMBL4839408 0.90 RORC (0.41) CA12CA1CA2CA4CA9
SCHEMBL4842917 0.88 FFAR4 (0.41) FFAR4RORCSMN1; SMN2MAPTALDH1A1
SCHEMBL4843247 0.87 FFAR4 (0.40) FFAR4RORCSMN1; SMN2MAPTALDH1A1
SCHEMBL4837553 0.87 FFAR4 (0.40) FFAR4RORCSMN1; SMN2MAPTALDH1A1
SCHEMBL4837997 0.87 FFAR4 (0.43) FFAR4RORCSMN1; SMN2ALDH1A1NPSR1
SCHEMBL4832552 0.87 FFAR4 (0.44) FFAR4CA1CA2CA9RORC
SCHEMBL4840740 0.86 FFAR4 (0.39) FFAR4RORCSMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 FFAR4 125/4885CA12 4875/4885CA1 4641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.